Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Dutawel
Dutawel (Dutasteride Capsules 0.5 mg) is a clinically proven medication for reducing prostate enlargement and improving urinary symptoms in men with benign prostatic hyperplasia (BPH).
Uses of Dutawel
Treatment of benign prostatic hyperplasia (BPH)
Reduces prostate size and improves urinary flow
Decreases the risk of acute urinary retention and need for surgery
May be used in combination with alpha-blockers for enhanced symptom relief
Benefits of Dutawel
Effectively lowers DHT levels, preventing further prostate growth
Relieves urinary symptoms and improves quality of life
Reduces the need for surgical intervention in BPH patients
Well-tolerated with a favorable safety profile
Mechanism of Action of Dutawel
Dutasteride inhibits the 5-alpha reductase enzyme, preventing the conversion of testosterone into dihydrotestosterone (DHT), the primary cause of prostate enlargement.